P R Conlin
Overview
Explore the profile of P R Conlin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
2592
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prentice J, Pizer S, Conlin P
Diabet Med
. 2016 Jun;
33(12):1640-1648.
PMID: 27279250
Aims: To characterize the relationship between HbA variability and adverse health outcomes among US military veterans with Type 2 diabetes. Methods: This retrospective cohort study used Veterans Affairs and Medicare...
2.
Goldfine A, Conlin P, Halperin F, Koska J, Permana P, Schwenke D, et al.
Diabetologia
. 2013 Feb;
56(4):714-23.
PMID: 23370525
Aims/hypothesis: Chronic sub-acute inflammation contributes to the pathogenesis of type 2 diabetes mellitus and cardiovascular disease. High doses of salicylate reduce inflammation, glucose and triacylglycerols, and may improve insulin sensitivity,...
3.
Williams J, Williams G, Raji A, Jeunemaitre X, Brown N, Hopkins P, et al.
J Hum Hypertens
. 2005 Nov;
20(2):129-36.
PMID: 16292348
Screening for primary hyperaldosteronism (PHA) is often indicated in individuals with resistant hypertension or hypokalaemia. However, in the far larger subset of the hypertensive population who do not fit into...
4.
Conlin P
Int J Clin Pract
. 2005 Apr;
59(2):214-24.
PMID: 15854200
Antihypertensive efficacy must be redefined beyond blood pressure (BP) lowering per se to include reducing the cardiovascular complications of hypertension. Treatment decisions should be based on results from large clinical...
5.
Williams J, Williams G, Jeunemaitre X, Hopkins P, Conlin P
J Hum Hypertens
. 2004 Sep;
19(2):133-8.
PMID: 15361890
We investigated the interplay of dietary sodium and renin-angiotensin-aldosterone system (RAAS) activity with the prevalence of left ventricular hypertrophy (LVH) in essential hypertension. Electrocardiograms (EKG) were reviewed for the presence...
6.
Vollmer W, Appel L, Svetkey L, Moore T, Vogt T, Conlin P, et al.
J Hum Hypertens
. 2004 Sep;
19(1):77-82.
PMID: 15361888
Ambulatory blood pressure monitoring (ABPM) is commonly used in clinical trials. Yet, its ability to detect blood pressure (BP) change in comparison to multiple office-based measurements has received limited attention....
7.
Romero J, Rivera A, Monari A, Ceolotto G, Semplicini A, Conlin P
J Hum Hypertens
. 2002 Jun;
16(5):353-8.
PMID: 12082497
Increased red blood cell sodium-lithium countertransport (SLC) activity and elevated intracellular calcium have been observed in hypertensive patients. The association of these ion transport abnormalities with each other and with...
8.
Erlinger T, Conlin P, Macko R, Bohannon A, Miller 3rd E, Moore T, et al.
J Hum Hypertens
. 2002 May;
16(6):391-7.
PMID: 12037693
Hypertension is associated with impaired fibrinolysis. Both angiotensin receptor blockers (ARB) and the DASH (Dietary Approaches to Stop Hypertension) diet effectively lower blood pressure in hypertensive patients. Some evidence suggests...
9.
Conlin P, Gerth W, Fox J, Roehm J, Boccuzzi S
Clin Ther
. 2002 Jan;
23(12):1999-2010.
PMID: 11813934
Background: It has been reported that a statistically greater percentage of patients initially treated with losartan, an angiotensin II receptor antagonist (AIIA), stayed on therapy at 1 year compared with...
10.
Vollmer W, Sacks F, Ard J, Appel L, Bray G, Simons-Morton D, et al.
Ann Intern Med
. 2001 Dec;
135(12):1019-28.
PMID: 11747380
Background: Initial findings from the Dietary Approaches to Stop Hypertension (DASH)-Sodium Trial demonstrated that reduction of sodium intake in two different diets decreased blood pressure in participants with and without...